Sriram Rajagopal

2.4k total citations
64 papers, 2.0k citations indexed

About

Sriram Rajagopal is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Sriram Rajagopal has authored 64 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 15 papers in Oncology and 10 papers in Pharmacology. Recurrent topics in Sriram Rajagopal's work include Antibiotics Pharmacokinetics and Efficacy (9 papers), Analytical Methods in Pharmaceuticals (7 papers) and Andrographolide Research and Applications (6 papers). Sriram Rajagopal is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (9 papers), Analytical Methods in Pharmaceuticals (7 papers) and Andrographolide Research and Applications (6 papers). Sriram Rajagopal collaborates with scholars based in India, United States and Spain. Sriram Rajagopal's co-authors include Srinivas Nanduri, Nitin Kumar, Rukkumani Rajagopalan, Chitkala Satyanarayana, Dhanvanthri S. Deevi, Ramesh Mullangi, Subhas Chakrabarty, Kuldeep Sharma, Shuang Huang and Sanjeev Giri and has published in prestigious journals such as Cancer Research, Analytical Biochemistry and Oncogene.

In The Last Decade

Sriram Rajagopal

63 papers receiving 1.9k citations

Peers

Countries citing papers authored by Sriram Rajagopal

Since Specialization

Citations

This map shows the geographic impact of Sriram Rajagopal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sriram Rajagopal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sriram Rajagopal more than expected).

Fields of papers citing papers by Sriram Rajagopal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sriram Rajagopal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sriram Rajagopal. The network helps show where Sriram Rajagopal may publish in the future.

Co-authorship network of co-authors of Sriram Rajagopal

This figure shows the co-authorship network connecting the top 25 collaborators of Sriram Rajagopal. A scholar is included among the top collaborators of Sriram Rajagopal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sriram Rajagopal. Sriram Rajagopal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	PAD4: pathophysiology, current therapeutics and future perspective in rheumatoid arthritis 2017 ·Expert Opinion on Therapeutic Targets ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Sriram Rajagopal	69
2	LC–MS/MS-ESI method for simultaneous quantification of darolutamide and its active metabolite, ORM-15341 in mice plasma and its application to a pharmacokinetic study 2017 ·Journal of Pharmaceutical and Biomedical Analysis ·(unknown), (unknown), Suresh P. Sulochana, (unknown), (unknown), (unknown), (unknown), Sriram Rajagopal, Ramesh Mullangi	13
3	Determination of ulixertinib in mice plasma by LC–MS/MS and its application to a pharmacokinetic study in mice 2016 ·Journal of Pharmaceutical and Biomedical Analysis ·(unknown), Suresh P. Sulochana, (unknown), (unknown), (unknown), (unknown), Sriram Rajagopal, Ramesh Mullangi	12
4	Orally available stilbene derivatives as potent HDAC inhibitors with antiproliferative activities and antitumor effects in human tumor xenografts 2015 ·European Journal of Medicinal Chemistry ·(unknown), Sridharan Rajagopal, (unknown), (unknown), (unknown), D. Prabhu, Praveen Rajendran, (unknown), Anshu M. Roy, (unknown), Narayanan Surendran, Sriram Rajagopal, Shridhar Narayanan, Balasubramanian Gopalan	7
5	Formulation development of an albendazole self-emulsifying drug delivery system (SEDDS) with enhanced systemic exposure / Razvoj samoemulzifirajućeg sustava za isporuku albendazola (SEDDS) s pojačanom sistemskom apsorpcijom 2012 ·Acta Pharmaceutica ·(unknown), Kuldeep Sharma, (unknown), Sriram Rajagopal, Ramesh Mullangi	41
6	Renal angioplasty and stenting: long-term results and the potential role of protection devices 2005 ·Expert Review of Cardiovascular Therapy ·Michel Henry, Isabelle Henry, (unknown), Sriram Rajagopal, (unknown), Michèle Hugel	14
7	Correlation Structure of the Equatorial Ionosphere 2004 ·Sriram Rajagopal, Todd Walter, Seebany Datta‐Barua, Juan Blanch, (unknown)	8
8	Preclinical evaluation of the anticancer activity of DRF-1042, a novel camptothecin analog targeting Topoisomerase-I. 2004 ·Cancer Research ·Sriram Rajagopal, (unknown), (unknown), (unknown), (unknown), Peter J. Houghton, (unknown), Rukkumani Rajagopalan	1
9	DRF 3188 a novel semi-synthetic analog of andrographolide: cellular response to MCF 7 breast cancer cells 2004 ·BMC Cancer ·Chitkala Satyanarayana, (unknown), Rukkumani Rajagopalan, Srinivas Nanduri, Sriram Rajagopal	79
10	Synthesis and structure–activity relationships of andrographolide analogues as novel cytotoxic agents 2004 ·Bioorganic & Medicinal Chemistry Letters ·Srinivas Nanduri, (unknown), (unknown), (unknown), (unknown), (unknown), Sriram Rajagopal, (unknown), (unknown), J. Moses Babu, (unknown), (unknown), G. Om Reddy, (unknown)	168
11	Anticancer and immunostimulatory compounds from Andrographis paniculata 2004 ·Journal of Ethnopharmacology ·(unknown), (unknown), Nitin Kumar, Srinivas Nanduri, Sriram Rajagopal	425
12	Andrographolide, a potential cancer therapeutic agent isolated from Andrographis paniculata 2003 ·PubMed ·Sriram Rajagopal, (unknown), Dhanvanthri S. Deevi, Chitkala Satyanarayana, Rukkumani Rajagopalan	266
13	Novel 6,7-diphenyl-2,3,8,8a-tetrahydro-1H-indolizin-5-one analogues as cytotoxic agents 2003 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), (unknown), (unknown), Pragya Prasanna, (unknown), A. Venkateswarlu, Sriram Rajagopal, (unknown), Dhanvanthri S. Deevi, Narsimha Mamidi, Rukkumani Rajagopalan	17
14	Novel indolo[2,1-b]quinazoline analogues as cytostatic agents: synthesis, biological evaluation and structure–activity relationship 2002 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Pragya Prasanna, (unknown), (unknown), Changqing Rao, Girijesh Kumar, (unknown), (unknown), (unknown), (unknown), A. Venkateswarlu, Sriram Rajagopal, (unknown), C. Seshagiri Rao, Narsimha Mamidi, Dhanvanthri S. Deevi, (unknown), Rukkumani Rajagopalan	141
15	Ectopic Expression of eIF-4E in Human Colon Cancer Cells Promotes the Stimulation of Adhesion Molecules by Transforming Growth Factorβ 2001 ·Cell Communication & Adhesion ·Sriram Rajagopal, Subhas Chakrabarty	1
16	Efficacy and specificity of antisense laminin chain-specific expression vectors in blocking laminin induction by TGF?1: Effect of laminin blockade on TGF?1-mediated cellular responses 1999 ·Journal of Cellular Physiology ·Sriram Rajagopal, (unknown), Hongmei Wang, Subhas Chakrabarty	8
17	Control of fibronectin receptor expression by fibronectin: Antisense fibronectin RNA downmodulates the induction of fibronectin receptor by transforming growth factor β1 1997 ·Journal of Cellular Physiology ·Sriram Rajagopal, Shuang Huang, Maher Albitar, (unknown)	12
18	Expression of antisense epidermal growth factor receptor RNA downmodulates the malignant behavior of human colon cancer cells 1995 ·Clinical & Experimental Metastasis ·Subhas Chakrabarty, Sriram Rajagopal, Shuang Huang	37
19	Epidermal growth factor expression in human colon and colon carcinomas: Anti‐sense epidermal growth factor receptor rna down‐regulates the proliferation of human colon cancer cells 1995 ·International Journal of Cancer ·Sriram Rajagopal, Shuang Huang, (unknown), Bang‐Ning Lee, Adel K. El‐Naggar, Subhas Chakrabarty	30
20	S1-nuclease enhancement of the ethidium bromide binding assay of drug-induced DNA interstrand crosslinking in human brain tumor cells 1990 ·Analytical Biochemistry ·Sriram Rajagopal, Francis Ali‐Osman	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact